Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASIMOMMY vs Domperidone for Breastfeeding
NCT05596006Phase 2Completed
- Sponsor
- Universitas Gadjah Mada
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Asimommy in hypogalactia (3 arms), sponsored by Universitas Gadjah Mada. Primary endpoint: Increase in Neonates Weight at 7 days. Started Dec 2022; status: completed.
02
Drugs
Asimommy
03
Conditions
hypogalactia
Beyond the preview
Go deeper on NCT05596006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05596006.